Sheng Jiang

Title: Innovations of Sheng Jiang in Biomedical Research

Introduction

Sheng Jiang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biomedical research, particularly in the development of novel drug compounds. With a total of 3 patents, his work focuses on addressing critical challenges in immunological therapies and disease treatment.

Latest Patents

Sheng Jiang's latest patents include a heterocyclic urea compound and a drug composition that specifically discloses an indoleamine-2,3-dioxygenase inhibitor. This invention aims to solve the issues of weak curative effects and the larger toxic and side effects associated with existing immunological therapy drugs. Additionally, he has developed histone deacetylase (HDAC) inhibitors, providing methods for their synthesis and applications in preparing pharmaceuticals for treating diseases related to HDAC dysregulation.

Career Highlights

Throughout his career, Sheng Jiang has worked with various companies, including Nanjing Yoko Biomedical R&D Ltd. and Nanjing Xingang Medical Co., Ltd. His expertise in drug development has positioned him as a key figure in the biomedical field.

Collaborations

Sheng Jiang has collaborated with notable professionals in his field, including Yiwu Yao and Shang Li. These collaborations have further enhanced his research and development efforts.

Conclusion

Sheng Jiang's innovative work in drug development and his contributions to biomedical research highlight his importance as an inventor. His patents reflect a commitment to improving therapeutic options for patients, showcasing the impact of his research on the medical community.